Karyopharm Therapeutics Secures $48,200,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69fcbbd5-bf9b-41da-bfea-67467530b0e3&Preview=1 - Date
5/20/2013 - Company Name
Karyopharm Therapeutics - Mailing Address
2 Mercer Road Natick, MA 01760 - Company Description
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. - Website
http://www.karyopharm.com - Transaction Type
Venture Equity - Transaction Amount
$48,200,000 - Transaction Round
Series B - Proceeds Purposes
The funds will be used to advance the Company’s pipeline of novel Selective Inhibitors of Nuclear Export (SINE) drug candidates for the treatment of advanced hematologic and solid tumors. - M&A Terms
- Venture Investor
Undisclosed - Venture Investor
Delphi Ventures - Venture Investor
Undisclosed
